BACKGROUND Morphea, also known as localized scleroderma, is a rare autoimmune connective tissue disease characterized by skin fibrosis. UVA1 phototherapy is an important asset in the reduction of clinical manifestations in morphea. There are studies claiming that UV light modulates the expression of some human endogenous retroviral sequences. The aim of this study was to determine if the expression of HERV-K10 gag element is lowered by UVA1 phototherapy in morphea, a disease in which such irradiation has a soothing effect. MATERIAL AND METHODS The expression levels of the HERV-K10 gag were assessed by real-time PCR (polymerase chain reaction) in peripheral blood mononuclear cells (PBMC) and skin-punch biopsies of healthy volunteers and 9 morphea patients before and after phototherapy. Additionally, correlations between the HERV-K10 gag expression and age, disease duration, the Localized Scleroderma Skin Severity Index (LoSSI), and antinuclear antibody (ANA) titers were assessed. RESULTS In PBMC, HERV-K10 gag mRNA was significantly elevated after UVA1 phototherapy compared to healthy controls. Most of the patients responded with an increased expression level of this sequence. However, we found no statistical evidence at this point that phototherapy indeed has an effect on the HERV-K10 gag expression (there were no statistical differences in PBMC of morphea patients before and after phototherapy). Similarly, there was no statistically relevant effect of the UVA1 on the expression of HERV-K10 gag in skin. CONCLUSIONS At this point, the effect of UVA1 phototherapy on the expression of HERV-K10 gag cannot be statistically confirmed.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292988 | PMC |
http://dx.doi.org/10.12659/msm.897985 | DOI Listing |
Cureus
July 2024
Laboratory of Virology, Oncology, Biosciences, Environment and New Energies, Faculty of Sciences and Techniques-Mohammedia, University of Hassan II Casablanca, Mohammedia, MAR.
J Emerg Dis Virol
August 2017
Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Background: It has been suggested that Human endogenous retroviruses (HERVs) are associated with multiple sclerosis (MS) pathogenesis. The objective of this study was to broadly evaluate the expression of HERV core (GAG) and envelope (ENV) genes in diseased brain white matter samples from MS patients compared to normal controls.
Methods: Twenty-eight HERV GAG and 88 ENV gene sequences were retrieved, classified by phylogeny, and grouped into clades.
Med Sci Monit
January 2017
Department of Dermatology, Poznań University of Medical Sciences, Poznań, Poland.
BACKGROUND Morphea, also known as localized scleroderma, is a rare autoimmune connective tissue disease characterized by skin fibrosis. UVA1 phototherapy is an important asset in the reduction of clinical manifestations in morphea. There are studies claiming that UV light modulates the expression of some human endogenous retroviral sequences.
View Article and Find Full Text PDFAIDS Res Hum Retroviruses
February 2015
1 Department of Medicine, Division of Hematology/Oncology, State University of New York, Upstate Medical University, Syracuse, New York.
Previously, we had shown that although only 8% of patients with large granular lymphocytic leukemia (LGLL) were infected with human T cell lymphoma/leukemia virus (HTLV)-2, almost half had antibodies to HTLV Gag and Env peptides. Herein, we investigated whether this could be due to cross-reactive antibodies to two homologous peptides in the Gag protein of the endogenous retrovirus HTLV-related endogenous sequence-1 (HRES-1). In addition, we had previously shown that patients with HTLV neurodegenerative diseases had increased seroreactivity to homologous HERV-K10 endogenous retrovirus peptides.
View Article and Find Full Text PDFJ Rheumatol
October 2014
From the Immunology Research Group, Research Institute in Healthcare Sciences, University of Wolverhampton; the Royal Wolverhampton National Health Service Trust, New Cross Hospital, Wolverhampton; Birmingham City University; the Department of Rheumatology, University Hospitals Birmingham National Health Service Foundation Trust, Queen Elizabeth Hospital, Birmingham; Sir Joseph Hotung Centre for Musculoskeletal Disorders; St. George's University of London; National Health Service Trust, London, United Kingdom.P.N. Nelson, BSc, PhD, DipTLHE; D. Roden, BSc, MSc; A. Nevill, BSc, PhD; G.L. Freimanis, BSc, MSc, PhD; M. Trela, BSc, MSc; H.D. Ejtehadi, BSc, PhD, PGCert, DipHE, Immunology Research Group, Research Institute in Healthcare Sciences, University of Wolverhampton, Birmingham City University; S. Bowman, PhD, FRCP; N. Tugnet, BmedSci, MBCHB, PG CertMedEd, MRCP, Department of Rheumatology, University Hospitals Birmingham National Health Service Foundation Trust, Queen Elizabeth Hospital; J. Axford, DSc, MD, FRCP, FRCPCH, Sir Joseph Hotung Centre for Musculoskeletal Disorders, St. George's University of London, National Health Service Trust; A.M. Veitch, BSc, MBBS, MD, FRCP; P.B. Rylance, BSc, MBBS, CertMedEd, FRCP; The Royal Wolverhampton National Health Service Trust, New Cross Hospital.
Objective: Human endogenous retrovirus (HERV)-K10 has been implicated in the etiology and pathogenesis of rheumatoid arthritis (RA). A secondary immune response to this virus might suggest an antigen-driven response in patients. The Gag region of HERV-K10 could provide a key epitope important for immunological reactivity.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!